对于失眠的认知行为疗法是否更具成本效益? 对经济评估的新视角:系统审查和元分析
Leqin Fang1,2, Zhihong Lyu1,2, Sizhi Ai3
1Department of Psychiatry, Sleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Sleep
|May 25, 2024
概括
对失眠的认知行为疗法 (CBTI) 比其他治疗方法更具成本效益. 数字CBTI (dCBTI) 也为患有失眠的成年人提供了经济效益和提高了疗效.
科学领域:
- 卫生经济学 卫生经济学
- 行为科学 行为科学
- 睡眠医学 睡眠医学
背景情况:
- 失眠严重影响成年人的幸福感和生产力.
- 失眠的认知行为疗法 (CBTI) 是一种成熟的治疗方法.
- 数字交付 (dCBTI) 提供了更广泛的可访问性和成本效益的潜力.
研究的目的:
- 系统地审查和元分析CBTI和dCBTI在成年失眠患者的成本效益.
- 将CBTI和dCBTI与对照组进行比较 (没有治疗,常规护理或睡眠卫生教育).
- 评估长期经济效益和治疗疗效.
主要方法:
- 在八个电子数据库中系统搜索CBTI的经济评估.
- 包括12个随机对照试验 (2004-2023年).
- 进行了元分析和子组分析,以确定成本效益和成本效益比率.
主要成果:
- 从医疗保健和社会角度来看,CBTI和dCBTI比控制干预更具成本效益.
- 与对照组相比,CBTI在12个月内显著提高了疗效.
- 虽然CBTI的初始医疗保健成本较高,但在12个月后均;dCBTI在6个月后显示降低了出席主义成本.
结论:
- CBTI是治疗成人失眠的一种具有成本效益的干预措施,提供长期的经济优势和持续的有效性.
- 数字CBTI (dCBTI) 为失眠管理提供了一种可行且具有成本效益的替代方案.
- 这些发现支持将CBTI和dCBTI整合到标准失眠护理中,以改善患者的治疗结果和经济效益.
更多相关视频
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
660
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
199
相关概念视频
01:27Insomnia
82
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
82
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:25Cognitive Therapy
152
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
152
01:24Rational Emotive Behavior Therapy
49
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
49
01:14CNS Depressants: Barbiturates and Benzodiazepines
250
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
250
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170